GlaxoSmithKline
Study: Researchers with Glaxo ties favored Avandia
...to heart disease had a financial connection to the firm. Most scientists who published articles supporting GlaxoSmithKline P.L.C.'s diabetes drug Avandia after it was linked to heart...
JavaScript and Flash are required to fully enjoy Evri
Most Avandia Supporters Have Ties To Glaxo
...a paper by a team of Mayo Clinic Researchers, who found most scientists who published articles supporting GlaxoSmithKline's Avandia diabetes pill after it was linked to a risk of heart...
GSK - Avandia: Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says
By Michelle Fay Cortez March 19 (Bloomberg) -- Most scientists who published articles supporting GlaxoSmithKline Plc's diabetes drug Avandia after it was linked to heart disease in 2007...
abcnews.go.com
business.timesonline.co.uk
business.timesonline.co.uk
reuters.com
Glaxo funded backers of 'danger' drug
...of people around the world with Type 2 diabetes. Avandia, made by the British multinational GlaxoSmithKline (GSK), which helps diabetics control their blood sugar levels, was linked...
GSK boosted as rival fears recede
To read this article in full you must be registered with the site. LONDON FTSE 100 CLOSE 5,642.62 -2.01 GLAXOSMITHKLINE led the FTSE 100 yesterday as fears eased over the threat...
Questor share tips: Glaxo is a yield play whatever happens Advair
However, whatever happens in the generic Advair situation, Glaxo shares still offer good value at these levels. Glaxo is not only a drugs company, but it is active in consumer...
Deal eases fears of competition to GSK asthma drug
...rights of a potential generic rival product. /quotes/comstock/23s!a:gsk GSK 1,270, +45.00, +3.67% GlaxoSmithKline /quotes/comstock/23s!a:gsk (UK:GSK 1,270, +45.00, +3.67%)...
"These findings, while not necessarily causal, underscore the need for further progress in reporting in order for the scientific record to be trusted," they said. A Glaxo spokeswoman said the company posted information and results from all its clinical trials on its Web site. "It's vital that people have trust in the way we do research and the way it's made public," Jo Revill, Glaxo spokeswoman, said yesterday. "Part of that is sharing data. What we have done is develop policies that will have disclosure and encourage disclosure."
Study: Researchers with Glaxo ties favored Avandia Philly.com | 2 days ago
GlaxoSmithKline gives FTSE 100 a lift
...turning back towards defensives this morning with pharmaceuticals on the up. Leading the charge was GlaxoSmithKline which ticked up 2.8pc after Novartis handed back US rights to a drug...
London Markets: GlaxoSmithKline shares outperform in FTSE 100
...White House and the GOP continues to apply pressure. Courtesy Fox News. GlaxoSmithKline /quotes/comstock/23s!a:gsk (UK:GSK 1,258, +33.14, +2.71%) /quotes/comstock/13*!gsk/quotes/nls/gsk...
UPDATE 1-Glaxo up as Novartis drops generic Advair in U.S.
...<NOVN.VX> has handed back U.S. rights to a drug widely believed to be a generic copy of GlaxoSmithKline's <GSK.L> lung blockbuster Advair, reducing the risk of cheap copies in Glaxo's...
STOCKS NEWS EUROPE-Glaxo up; generic Advair threat recedes
GlaxoSmithKline <GSK.L> gains 2.7 percent after Novartis <NOVN.VX> hands back U.S. rights to a drug widely thought to be a generic copy of its blockbuster Advair, reducing the threat of...
